RITUXIMAB IMPROVES QUALITIY OF RESPONSE AND SURVIVAL IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A POPULATION-BASED STUDY